Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Pfizer Inc. recalls Buprenorphine Hydrochloride Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Products
  • Buprenorphine Hydrochloride Injection
Where it was sold

US Nationwide and Puerto Rico.

Nationwide

Units affected
84,710 cartridges
About this recall
Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03